DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ethambutol
Ethambutol
Para-Aminosalicylic Acid – Biopharmaceutical, Pharmacological
Treatment of Tuberculosis in Adults and Children Guideline Version 3.0 March 2021
1 Application to 21St WHO Expert Committee on the Selection And
Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R
Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid–Sulfamethazine Cocrystals
Customs Tariff - Schedule
Alphabetical Listing of ATC Drugs & Codes
Frequently Asked Questions on The
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Concept Note Dose Optimization of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in the Treatment of Drug-Susceptible Tuberculosis
Estonian Statistics on Medicines 2013 1/44
Tuberculosis Drug Information Guide, 2Nd Edition
Antimicrobial Resistance in Bacteria
Trecator (Ethionamide Tablets, USP)
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Review of Existing Classification Efforts
TB Eliminationtreatment of Multidrug-Resistant Tuberculosis
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Top View
WHO/CDS/TB/2003.313 Treatment of Tuberculosis: Guidelines for National Programmes, Third Edition Revision Approved by STAG, June 2004
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
The Use of Bedaquiline in the Treatment of Multidrug-Resistant
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
Tuberculosis Treatment Guidelines
Synthesis and Evaluation of Mutual Prodrugs of Isoniazid, P-Amino Salicylic Acid and Ethambutol
Pharmacokinetics and Dosing Rationale of Para
Part 4 October 2017 Hydrochloride 150Mg/75Mg/400Mg/275Mg Film-Coated Section 7 Updated: April 2020 Tablets, (Micro Labs Limited), TB 223
Chapter 6 Treatment of Tuberculosis Disease
TB Regimens and Dose Schedules.Pdf
E.Johnson Supplementary
TB Elimination
Part 4 May 2016 Film-Coated Tablets Suppliers Submission of the (Antibiotice S
Bedaquiline (Sirturo®)
An Activist's Guide to Tuberculosis Drugs 2016 Update
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Antibiotic Exposure Prior to Hospital Admission for Acute Liver Injury
MYAMBUTOL (Ethambutol Hcl) Tablets
Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy (2006)
Drug Utilization Patterns Among Elderly Hospitalized Patients on Poly
SIRTURO (Bedaquiline) Label
Pharmaceuticals Appendix
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Opposing Effects of Target Overexpression Reveal Drug Mechanisms
ICD-10-CM Table of Drugs 2019
1.14.2.3 Final Labeling Text the Final Labeling for Ethambutol Hcl Tablets
Design and Synthesis of Next Generation Propargyl-Linked Antifolates Eric Scocchera
[email protected]
FAQ Bedaquiline Implementation
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm
Simultaneous Detection of Ethambutol and Pyrazinamide with IL
VA San Francisco Guide to Antimicrobials
Ethambutol in Tuberculosis: Time to Reconsider? Arch Dis Child: First Published As 10.1136/Adc.79.3.274 on 1 September 1998
Tuberculosis Adverse Drug Events